Aligos therapeutics begins dosing with capsid assembly modulator drug candidate, alg-000184, in first cohort of chronic hepatitis b patients in a phase 1 proof-of-concept study

Aligos now evaluating two of its four chronic hepatitis b (chb) portfolio drug candidates in patients aligos now evaluating two of its four chronic hepatitis b (chb) portfolio drug candidates in patients
ALGS Ratings Summary
ALGS Quant Ranking